Marshall Financial Group LLC trimmed its holdings in Relx Plc (NYSE:RELX - Free Report) by 68.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,613 shares of the technology company's stock after selling 20,902 shares during the period. Marshall Financial Group LLC's holdings in Relx were worth $437,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of RELX. Versant Capital Management Inc acquired a new position in Relx during the fourth quarter valued at approximately $31,000. Private Trust Co. NA grew its stake in Relx by 119.9% in the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company's stock valued at $49,000 after buying an additional 566 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Relx in the 3rd quarter worth $125,000. Grove Bank & Trust lifted its position in Relx by 10.2% during the 3rd quarter. Grove Bank & Trust now owns 3,758 shares of the technology company's stock worth $178,000 after acquiring an additional 348 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in Relx by 33.9% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 3,952 shares of the technology company's stock valued at $188,000 after acquiring an additional 1,000 shares during the period. Institutional investors own 15.02% of the company's stock.
Relx Stock Performance
Relx stock traded down $0.55 during mid-day trading on Friday, reaching $48.85. The company had a trading volume of 788,883 shares, compared to its average volume of 393,573. The company has a debt-to-equity ratio of 1.63, a current ratio of 0.48 and a quick ratio of 0.42. The company has a 50 day moving average of $46.73 and a 200-day moving average of $46.69. Relx Plc has a 52 week low of $40.25 and a 52 week high of $49.57.
Analysts Set New Price Targets
A number of equities analysts have recently commented on RELX shares. StockNews.com started coverage on Relx in a research note on Wednesday, October 30th. They issued a "hold" rating on the stock. Redburn Atlantic initiated coverage on Relx in a research report on Wednesday, January 8th. They issued a "buy" rating on the stock.
Read Our Latest Stock Analysis on Relx
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
